Background: Hypertriglyceridemia is associated with increased risk of cardiovascular disease. Until recently, the importance of hepatic de novo lipogenesis (DNL) in contributing to hypertriglyceridemia was difficult to assess because of methodologic limitations.
Objective: We evaluated the extent of the contribution by DNL to different conditions associated with hypertriglyceridemia.